Performance evaluation of noninvasive lipid measurement device by fat load test

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000027559
• Lead Sponsor: Hokkaido Information University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-05-31
• Study Completion: 2017-06-26
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Not provided

Exclusion Criteria

1.Subjects using anticoagulants (such as warfarin), antiplatelet drugs (aspirin, clopidogrel, ticlopidine, cilostazol etc.), coagulation accelerators (calcium solution, thrombin, vitamin K, etc.). 2.Subjects with blood clotting disease (hemophilia, platelet asthenia, warfarin administration, liver failure, etc). 3.Subjects who may have allergic symptoms in dairy products. 4.Subjects who received physician treatment, medication, and life guiduance for obesity, dyslipidemia, diabetes. 5.Subjects suffering from severe cerebrovascular disease, heart disease, liver disease, kidney disease, gastrointestinal disease, endocrine metabolic disease, infection requiring notification. 6.Subjects using pacemakers and defibrillators. 7.Subjects who have injuries, atopic skin diseases, contact dermatitis, rashes, etc. on the skin of the upper arm. 8.Subjects with major surgical history relevant to the digestive system. 9.Subjects with unusually high, low blood pressure, abnormal hematological data, severe anemia. 10.Pre- or post-menopausal women complaining of obvious physical changes. 11.Excess smokers and regulars alcohol addicts or subjects with eating disordered lifestyle. 12.Subjects who donated a predetermined amount of blood in a given period. 13.Pregnant or lactating women or women who expect to be pregnant during this study. 14.Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the current study. 15.Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified